Last reviewed · How we verify
YH004
At a glance
| Generic name | YH004 |
|---|---|
| Sponsor | Eucure (Beijing) Biopharma Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma (PHASE1)
- Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |